TS-072613 — A novel vaccine and diagnostic platform targeting the conserved Ehrlichia virulence factor RipE offers the first pan-Ehrlichia solution for preventing and detecting tick-borne ehrlichiosis in humans and animals.
Tick-borne ehrlichiosis cases continue to rise globally, yet no licensed human vaccine exists and current diagnostic tools remain limited. Existing approaches struggle due to the pathogen’s antigenic variability, intracellular lifecycle, and lack of classical surface PAMPs, hindering effecti…